Download PDF
Thromb Haemost 1973; 30(03): 577-585
DOI: 10.1055/s-0038-1649136
Original Article
Schattauer GmbH

Effect of Aspirin and Benadryl on Human Platelet Oxidative Phosphorylation and Aggregation

Kenneth T. N. Yue
1   Hematology Research Laboratory, Veterans Administration Hospital, Kansas City, Missouri 64128
2   Departments of Pathology and Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66103
,
James W. Davis
1   Hematology Research Laboratory, Veterans Administration Hospital, Kansas City, Missouri 64128
2   Departments of Pathology and Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66103
,
E. Gray Aldridge
1   Hematology Research Laboratory, Veterans Administration Hospital, Kansas City, Missouri 64128
2   Departments of Pathology and Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66103
› Author Affiliations
Further Information

Publication History

Received 20 April 1973

Accepted 14 August 1973

Publication Date:
30 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Tightly coupled oxidative phosphorylation in washed human platelets and in lysates has been demonstrated. Both aspirin (25 μM) and Benadryl (0.15 mM) inhibited phosphorylating oxidation but had no effect on uncoupled respiration. It is likely that they were not involved in the electron transport chain but specifically affected the phosphorylation reactions similar to the action of oligomycin. Preincubation of Benadryl (1.3 mM) with platelet-rich plasma (PRP) at room temperature for 2 min inhibited ADP-induced platelet aggregation by 62% and abolished the second phase of aggregation. Addition of Benadryl to aggregating platelets in PRP during ADP-induced aggregation caused immediate disaggregation whether added during the first or second phase of aggregation. Aspirin had no such effect.

 

  • References

  • 1 Al-Mondhiry H, Marcus A. J, and Spaet T. H. 1970; On the mechanism of platelet function inhibition by acetylsalicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 630.
    PubMedGoogle Scholar
  • 2 Ardlie N. G, Packham M. A, and Mustard J. F. 1970; Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. British Journal of Haematology 19: 7.
    CrossrefPubMedGoogle Scholar
  • 3 Barber A. J, and Jamieson G. A. 1970; Isolation and characterization of plasma membranes from human blood platelets. Journal of Biological Chemistry 245: 6357.
    PubMedGoogle Scholar
  • 4 Brody T. M. 1956; Action of sodium salicylate and related compounds on tissue metabolism in vitro. Journal of Pharmacology and Experimental Therapeutics 117: 39.
    PubMedGoogle Scholar
  • 5 Bruni A, Contessa A. R, and Scalella P. 1965; The binding of atractyloside and oligomycin to liver mitochondria. Biochimica et Biophysica Acta 100: 1.
    CrossrefPubMedGoogle Scholar
  • 6 Chernyak N. B. 1965; Processes of formation and utilization of energy in human blood platelets. Clinica Chimica Acta 12: 244.
    CrossrefPubMedGoogle Scholar
  • 7 Doery J. C. G, Hirsh J, and De Gruchy G. C. 1969; Aspirin: Its effect on platelet glycolysis and release of adenosine diphosphate. Science 165: 65.
    CrossrefPubMedGoogle Scholar
  • 8 Doery J. C. G, Hirsh J, and Cooper I. 1970; Energy metabolism in human platelets: Interrelationship between glycolysis and oxidative metabolism. Blood 36: 159.
    PubMedGoogle Scholar
  • 9 Holmsen H, Day H. J, and Stormorken H. 1969 The blood platelet release reaction. Scandinavian Journal of Haematology, Supplementum No. 8.
    PubMedGoogle Scholar
  • 10 Kinlough R. L, Packham M. A, and Mustard J. F. 1969; Glucose and platelet aggregation. Federation Proceedings 28: 509.
    PubMedGoogle Scholar
  • 11 Lowry O. H, Rosebrough N. J, Farr A. L, and Randall R. J. 1951; Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 265.
    PubMedGoogle Scholar
  • 12 Macmillan D. C. 1966; Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline. Nature 211: 140.
    CrossrefPubMedGoogle Scholar
  • 13 McElroy F. A, Kinlough-Rathbone R. L, Ardlie N. G, Packham M. A, and Mustard J. F. 1971; The effect of aggregating agents on oxidative metabolism of rabbit platelets. Biochimica et Biophysica Acta 253: 64.
    CrossrefPubMedGoogle Scholar
  • 14 Mills D. C. B, and Roberts G. C. K. 1967; Membrane active drugs and the aggregation of human blood platelets. Nature 213: 35.
    CrossrefPubMedGoogle Scholar
  • 15 Mürer E. H. 1968; Release reaction and energy metabolism in blood platelets with special reference to the burst in oxygen uptake. Biochimica et Biophysica Acta 162: 320.
    CrossrefPubMedGoogle Scholar
  • 16 O’Brien J. R. 1968; Effects of salicylates on human platelets. Lancet 1: 779.
    PubMedGoogle Scholar
  • 17 O’Brien J. R. 1961; The adhesiveness of native platelets and its prevention. Journal of Clinical Pathology 14: 140.
    CrossrefPubMedGoogle Scholar
  • 18 Rock R. C, and Nemerson Y. 1969; Energetics of human blood platelets: Uncoupling of oxidative phosphorylation in intact cells. Journal of Laboratory and Clinical Medicine 73: 42.
    PubMedGoogle Scholar
  • 19 Weiss H. J, Aledort L. M, and Kochwa S. 1968; The effect of salicylates on the hemostatic properties of platelets in man. Journal of Clinical Investigation 47: 2169.
    CrossrefPubMedGoogle Scholar
  • 20 Zucker M. B, and Peterson J. 1968; Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society for Experimental Biology and Medicine 127: 547.
    PubMedGoogle Scholar